Bharat Biotech's needle-free intranasal Covid vaccine for booster dose. (IANS) Covid vaccine
Health

Bharat Biotech's intranasal booster vaccine gets Centre's approval

The Centre on Friday approved Bharat Biotech's needle-free intranasal Covid vaccine for booster dose, said an official source.

NewsGram Desk

The Centre on Friday approved Bharat Biotech's needle-free intranasal Covid vaccine for booster dose, said an official source.

The nassal vaccine has been approved for those aged above 18 years. The vaccine will be available in the private hospitals for booster dose in the initial phase.

The source said that the nasal vaccine will be used as a heterologous booster among the eligible population. Meanwhile, the intranasal Covid vaccine is also expected to be introduced in the Covid-19 vaccination program from Friday, said the source.

The nasal vaccine is likely to be added to the CoWIN App from this day only.

Meanwhile, India on Friday reported 163 fresh Covid-19 cases along with nine deaths have also been reported in the country. The number of active coronavirus cases declined to 3,380. (SJ/IANS)

How to Store Vape Juice in Good Condition

Book Your Airport Taxi Limo Service Today for a Smooth and Stylish Arrival

American Children Who Appear to Recall Past-Life Memories Grow Up to Be Well-Adjusted Adults

In the ‘Wild West’ of AI Chatbots, Subtle Biases Related to Race and Caste Often Go Unchecked

Future of Education with Neuro-Symbolic AI Agents in Self-Improving Adaptive Instructional Systems